Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Organo-ID logo — Preclinical Disease Models via Organoid technologies

Organo-ID

Preclinical Disease Models via Organoid technologies

Founded 2020 Turkey Turkey 7 employees Convertible Note Total: $200.00K Biotechnology, Health Care

General Information

Company Name Organo-ID
Founded Year 2020
Location Turkey Turkey +1
Founders / Decision Makers
Team member
Employees 7
Industries Biotechnology, Health Care
Funding Stage Convertible Note
Social

Get notified when Organo-ID moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Organo-ID

Organo-ID is a biotechnology startup based in Turkey, founded in 2020. The company specializes in creating pre-clinical in vitro disease models through the utilization of organoid technologies, with a particular focus on human cancer and liver pathologies. Their mission is to revolutionize the understanding and treatment of these diseases. Most notably, their recent funding round of $100.00KConvertible Note was secured on 06 July 2022 from Idacapital, reflecting growing investor interest in their innovative approach. Organo-ID's dedication to cutting-edge technologies and its potential impact in the health care industry makes it a compelling prospect for venture capital investment.

Taxonomy: Preclinical Disease Models, In vitro disease models, Organoid technologies, Human cancer, Liver pathologies, Metabolic liver disease, Rare diseases, Cancer treatment response testing, Personalized oncology, 3D cell culture, iPSC, Stem cell expertise

Services & Products

development of pre-clinical disease models
organoid technology commercialization
personalized drug testing services

Target Customers

Pharmaceutical companies research institutions oncologists precision medicine centers biobanks

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Convertible Note - Organo •••••• 1
Investor
06 Jul 2022
Pre Seed Round - Organo •••••• 1
Investor
16 Aug 2020

Organo-ID Alternatives & Competitors

Organo-ID vs
MIMETAS
MIMETAS The Netherlands

Human Tissue Models for Better Therapies

Grant
93 employees
Biotechnology, Health Care
Organo-ID vs
HepaTx Corporation
HepaTx Corporation United States

Off-the-shelf cell therapies for liver disease

Seed
3 employees
Biotechnology, Health and Wellness
Organo-ID vs
Promethera Biosciences
Promethera Biosciences

Innovative biopharmaceuticals harnessing healthy human liver cells to treat liver diseases with grou...

Series D
11-50 employees
Biotechnology, Health and Wellness

FAQ About Organo-ID

Preclinical Disease Models via Organoid technologies
Organo-ID was founded in 2020.
Organo-ID is headquartered in Turkey.
Organo-ID operates in the following industries: Biotechnology, Health Care.
Organo-ID has approximately 7 employees.
Organo-ID has completed 2 funding rounds, raising a total of $200.00K. The latest funding stage is Convertible Note.
Organo-ID offers: development of pre-clinical disease models, organoid technology commercialization, personalized drug testing services.
Top alternatives and competitors to Organo-ID include MIMETAS, HepaTx Corporation, Promethera Biosciences, Hunterdon Gastroenterology Associates, Base Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Organo-ID and MIMETAS are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Organo-ID and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes